Phase of Trial: Phase III
Latest Information Update: 21 Apr 2009
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Huntington's disease
- Focus Registrational; Therapeutic Use
- Acronyms TREND-EU
- 21 Apr 2009 New trial record.
- 09 Apr 2009 Marketing Authorization Application has been accepted for review by the European Medicines Agency, according to a Amarin Corporation media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History